Revium Rx Shifts Focus with Acquisition of LipoVation Ltd., Advancing Nanoparticle-Based Drug DevelopmentIsrael, Feb. 04, 2025 (GLOBE NEWSWIRE) -- – Revium Rx (formerly Revium Recovery Inc., OTC: RVRC ...

[77] The described examples of liposomes as nanocarriers for the delivery of anti-TB drugs using passive and active targeting, as well as some anti-TB drugs efficiently incorporated in liposomes ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state ...

Emcure Pharmaceuticals Limited, one of India's leading pharma companies announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.

Ahmedabad: Emcure Pharmaceuticals Limited has announced the inauguration of its state-of-the-art Formulation Research and ...

[76] Targeted delivery of immunoliposomes was examined for cancer therapy (Figure 3E). Cancer cell-targeting antibodies (HER2/neu and CD20 antibodies) were conjugated on the liposomal surface.

HOUSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop ...

InnoCan Pharma ( ($TSE:INNO) ) has issued an announcement. Innocan Pharma’s subsidiary, BI Sky Global, has completed the Human Repeated Insult ...

Inc. is a biotechnology company specializing in the development of nucleic acid cancer and obesity drugs using its proprietary DNAbilize® liposomal delivery and antisense technology. The company ...